<DOC>
	<DOCNO>NCT00141986</DOCNO>
	<brief_summary>Type 1 diabetes common chronic disease childhood . It yet preventable . Multiple daily injection insulin , test blood sugar , careful dietary planning require lifelong prevent long-term complication blindness kidney failure . Recent study potential risk factor child diabetes , along study reveal immunologic property vitamin D , experiment animal suggest high dos vitamin D may prevent type 1 diabetes . For proof human child , randomize trial compare group risk randomly assign receive either usual vitamin D supplement high amount , 2000 IU daily . This initial study small scale test procedure .</brief_summary>
	<brief_title>Feasibility Study 2000 IU Per Day Vitamin D Primary Prevention Type 1 Diabetes</brief_title>
	<detailed_description>Type 1 diabetes multifactorial disease strong genetic non-genetic component disease susceptibility . The uniquely strong genetic risk factor region , human leukocyte antigen region chromosome 6p , contribute approximately half genetic component use screening diabetes risk . For example , individual high risk compound heterozygote genotype comprise 2 % general population , twenty fold increase risk type 1 diabetes absolute risk approximately 7 % age 15 year . Studies non-inherited component diabetes susceptibility implicate external environmental factor operate first year life , suggest possibility reverse trend correct intervention . Recent data suggest vitamin D system potentially important target therapeutic intervention prevent type 1 diabetes . These data include epidemiological study show vitamin D supplementation infancy associate substantially decrease subsequent risk disease , animal work non-obese diabetes mouse model autoimmune diabetes show incidence autoimmune diabetes increase animal nutritionally deprive vitamin D , disease prevent use 1,25-dihydroxyvitamin D , non-hypercalcemic vitamin D analogue . In vitro experiment suggest prevention see NOD mouse may due combined effect vitamin D antigen present cell activate T-cells . Based epidemiological animal model study , hypothesize administration infancy cholecalciferol , usual nutritional supplement form vitamin D , increase dose 2000 IU/day ( instead current practice 400 IU/day ) prevent type 1 diabetes child general population increase genetic risk . The main objective proposal pilot two-arm randomized control trial compare two dos . The participant infants general population identify increase genetic risk type 1 diabetes cord blood filter paper blood spot HLA class II genetic screening . The study measure key safety , compliance pharmacokinetic , surrogate efficacy , process outcome include growth parameter , 25-hydroxyvitamin D 1,25-dihydroxyvitamin D level , calcium level blood urine , bone mineral content body composition densitometry , diabetes-related autoantibody marker beta-cell autoimmunity , recruitment rate screen intervention trial .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>HLA genotypes increase risk type 1 diabetes : heterozygous DRB1*03 , DQA1*0501 , DQB1*0201 / DRB1*04 , DQA1*03011 , DQB1*0302 ( DRB1*04 ≠ *0403 related allele ) , homozygous DRB1*03 , DQA1*0501 , DQB1*0201 , homozygous DRB1*04 , DQA1*03011 , DQB1*0302 ( DRB1*04 ≠ *0403 related allele ) . Premature , low birthweight , major congenital malformation serious chronic disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>4 Weeks</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>vitamin D</keyword>
	<keyword>type 1 diabetes</keyword>
	<keyword>prevention trial</keyword>
</DOC>